This study further examines the role of the CCL2/MCP-1 axis in colorectal cancer via antibody mediated blockade of CCL2 combined with 5-FU chemotherapy in Balb/c mice with subcutaneous CT26 colon carcinoma allografts. This evidence concerns the gene CCL2 and colon carcinoma.